IndexIQ Advisors’s Colgate-Palmolive CL Stock Holding History

IndexIQ Advisors’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.14M	Sell	15,071 -19	-0.1%	-$1.5K	0.04%	261
2021 Q4	$1.29M	Buy	15,090 +438	+3%	+$34.2K	0.04%	267
2021 Q3	$1.11M	Buy	14,652 +688	+5%	+$54.6K	0.04%	293
2021 Q2	$1.14M	Buy	13,964 +258	+2%	+$21.1K	0.04%	270
2021 Q1	$1.08M	Buy	13,706 +1,720	+14%	+$135K	0.04%	255
2020 Q4	$1.02M	Buy	11,986 +5,618	+88%	+$465K	0.04%	234
2020 Q3	$491K	Buy	6,368 +3,833	+151%	+$292K	0.02%	280
2020 Q2	$186K	Buy	2,535 +2,239	+756%	+$159K	0.01%	662
2020 Q1	$20K	Sell	296 -2	-0.7%	-$141	﹤0.01%	792
2019 Q4	$21K	Buy	+298	New	+$20.3K	﹤0.01%	589

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

IndexIQ Advisors's CL Position: Q1 2022 in Review

IndexIQ Advisors reduced its Colgate-Palmolive (CL) stake by 0.13% in Q1 2022, selling an estimated $1.5K and leaving 15,071 shares worth $1.14M. The position accounts for 0.04% of the portfolio, ranked #261.

IndexIQ Advisors first reported a position in CL in Q4 2019 and has held it in 10 quarters since. The position peaked at $1.29M in Q4 2021. 1,632 funds tracked by Wall St. Rank hold CL as of Q1 2022.

IndexIQ Advisors held 15,071 shares of Colgate-Palmolive worth $1.14M as of Q1 2022.
IndexIQ Advisors sold 19 Colgate-Palmolive shares in Q1 2022, an estimated $1.5K.
Colgate-Palmolive made up 0.04% of IndexIQ Advisors's portfolio in Q1 2022, its #261 holding.
IndexIQ Advisors first reported a position in Colgate-Palmolive in Q4 2019 and has held it in 10 quarters since.
IndexIQ Advisors's Colgate-Palmolive position peaked at $1.29M in Q4 2021.
1,632 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.